Igenesis
PrivateLast Round
Series B
Extension
Aug 26, 2021
Total Funding Raised
$85.4M
Company Overview
Igenesis operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in August 2021.
Igenesis is a biotechnology company that develops and manufactures automated PCR analysis platforms, medical diagnostic tools, and nucleic acid extraction kits for healthcare and forensic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Igenesis Comparables
Compare Igenesis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ustar Biotechnologies (Hangzhou) Ltd. | 86% | |
| Coyote Bioscience Co., Ltd. | 84% | |
| Daan Gene Co., Ltd. | 76% |
For institutional investors. Book with your work email.
Igenesis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 26, 2021 | ||||
| Series B | Jun 15, 2021 |
For institutional investors. Book with your work email.
Igenesis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Huimei Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Monthly visitors increased 627% MoM, reaching 5.7K.
For institutional investors. Book with your work email.
Igenesis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Igenesis's valuation, stock price, and market status.
Is Igenesis a public or private company?
Igenesis is a private company.
What is the current stock price of Igenesis?
Igenesis is a private company, so its shares have no public market price. Caplight tracks Igenesis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Igenesis worth (valuation)?
Valuation information for Igenesis is not publicly available.
Can I buy Igenesis stock?
Igenesis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Igenesis's last funding round?
Igenesis's most recent funding round was Series B Extension on August 26, 2021.
Who are the main investors in Igenesis?
Key investors in Igenesis include Huimei Capital.
Will Igenesis IPO soon?
No public IPO plans have been announced for Igenesis.
How can I track Igenesis secondary market activity?
Caplight tracks bids, offers, and trades in Igenesis's shares on secondary markets.